CS Paper Radar

Improving the Clinical Generalizability of Machine Learning-Based Alzheimer's Disease Detection Across Domains and Modalities: A Comprehensive Review

Yingchao Huang, Yuhan Su, Xin Wang, Shanshan Yao

eess.AS ·submitted 2026-11-05 15:45 UTC · v1
published

Abstract

Objective: This review aims to provide a comprehensive synthesis of domain adaptation (DA) and domain general- ization (DG) strategies for AD detection. It focuses on their potential to improve the robustness, generalizability, and clinical reliability of ML-based diagnostic systems. Methods: We conduct a comprehensive scoping review of existing DA and DG approaches across multiple data modalities. The reviewed studies are organized according to data modality, algorithmic framework, adaptation strat- egy, clinical relevance, and reported cross-domain performance. Key methodological trends, performance gains, limitations, and remaining challenges are analyzed to identify future research directions. Results: DA and DG approaches have demonstrated encouraging improvements in cross-domain performance and model robustness. Emerging modalities, such as speech-based approaches, EEG and eye-tracking data, show great po- tential for early, accessible, and non-invasive cognitive assessments. However, important limitations remain, including insufficient external validation, limited interpretability, computational complexity, privacy concerns, and challenges in scaling to routine clinical practice. Conclusion: DA and DG provide important methodological pathways for developing more generalizable ML-based systems for AD detection. Future research should prioritize explainable, computationally efficient, privacy-preserving, and clinically validated DA/DG techniques. Strengthening these aspects will be essential for translating robust AI- based AD detection tools into clinically deployable solutions.

Comment
This paper has been accepted by the Journal of Alzheimer's Disease

Closest papers

Nearest neighbours by meaning across the whole index.

Robust Cross-Domain Speech-Based Alzheimer's Disease Detection via Iterative Adversarial Self-Training

cs.SD eess.AS ·2026-09-12 ·Luqi Sun, Shreeram Suresh Chandra, Aurosweta Mahapatra, Emily Mower Provost, Brian MacWhinney +1 more
similarity 0.74
Abstract

As Alzheimer's disease (AD) has increasingly become a major global public health issue, speech-based AD detection has attracted widespread attention. However, most existing methods are trained and evaluated on a single dataset, often leading to severe cross-domain performance degradation due to reliance on dataset-specific artifacts rather than disease-related speech cues. In real-world applications, reliable Alzheimer's disease detection requires models that are robust to variations in recording environments, speakers and data collection conditions. To address this challenge, this paper adopts unsupervised domain adaptation to learn robust, domain-invariant feature representations in the absence of target-domain diagnosis labels. On this basis, a novel unsupervised domain adaptation method, Iterative Adversarial Self-Training (IAST), is proposed. Results demonstrate that IAST significantly improves the generalization ability and robustness under various cross-domain settings.

0.22

Emergence of Transfer Learning towards Specific Identification of Alzheimer's Disease A Prospective Approach

cs.CV cs.DL ·2026-08-13 ·Soumik Podder, Chandramouli Haldar
published similarity 0.66
Abstract

Worldwide, millions of senior citizens are suffering from Alzheimer disease abbreviated as AD, a well- versed form of dementia. AD is featured by amnesia, intellectual disability, and difficulty with consciousness. DL and ML models are undoubtedly explored to identify AD related patterns on large dimensional neuroimaging data but they need global optimization and are suffering from overfitting issue that might yield dissatisfactory result in testing data set. DL overcomes the issue by convolution of input image with kernel but any sudden change in the MRI image or human manipulation, limited pre- processing of the images can mislead CNN in achieving highly accurate detection. Transfer Learning (TL) has proved itself in AD diagnosis by utilizing pre-trained models on large data sets to guide novice model in a new neuroimaging dataset. This review provides an inclusive glimpse of TL implication in classification, identification including the conversion of AD. Keeping in view, we have assessed the strengths and limitations of TL in improvising diagnostic accuracy even with limited data. The uniqueness of the present review is the incorporation of explainable AI in TL based AD diagnosis system. Finally, it can be claimed that the review will guide the new re-searchers in the area of TL induced neurodegenerative disease detection.

0.58

Cleaner Speech, Weaker Generalization: Revisiting Pitt-Derived Benchmarks for Alzheimer's Disease Detection

cs.SD cs.AI ·2026-08-31 ·Luqi Sun, Shreeram Suresh Chandra, Lin Zhang, You-Jin Li, Brian MacWhinney +3 more
similarity 0.65
Abstract

Speech-based Alzheimer's disease (AD) detection increasingly relies on speech-enhanced and curated versions of the Pitt Corpus, where speech enhancement, sample selection, and demographic balancing are often treated as beneficial preprocessing steps. However, whether these transformations improve real-world AD detection or instead affect model generalization and prediction behavior remains unclear. In this work, we revisit the role of speech preprocessing and dataset curation across widely used benchmarks for speech-based AD detection. We evaluate the speech quality of different datasets, the cross-dataset generalization of multiple deep learning models under matched and mismatched enhancement settings, and the behavior of several recent large audio-language models (LALMs). Experimental results show that across multiple supervised speech models, speech-enhanced datasets often improve in-domain performance while reducing robustness in cross-domain evaluation. Matched enhancement between training and test data alleviates, but does not eliminate, this degradation. LALMs show a similar sensitivity: enhanced datasets induce stronger class imbalance and prediction shifts than unprocessed data. These results suggest that speech preprocessing and dataset curation can substantially influence downstream AD detection behavior, indicating that ``cleaner'' speech datasets are not necessarily more reliable for real-world AD detection.

0.22

Cross-disorder Learning of Imaging-derived Joint Mophometric Markers in Alzheimer's and Parkinson's Diseases

cs.LG q-bio.QMq-bio.NC ·2026-10-19 ·Yuji Zhao, Boris Gutman
code/datahot direction similarity 0.65
Abstract

As two most prevalent neurodegenerative diseases (NDDs), Alzheimer's disease (AD) and Parkinson's disease (PD) shared commonalities both in symptomology and pathophysiology. However, to what extent and in what way these two distinct disorders overlap remain underexplored. In this study, we propose an explicit, interpretable and spatially adaptive transfer learning framework to elucidate the morphometric biomarkers linked to AD and PD. We applied such high-dimensional machine learning model to two most popular open-source neuroimaging datasets, i.e., Alzheimer's Disease Neuroimaging Initiative (ADNI) and Parkinson's Progression Markers Initiative (PPMI). On the one hand, our cross-disorder classifier revealed neuro-anatomical alteration patterns well aligning with previous neuroimaging research findings and underscoring patients' clinical presentations. On the other hand, the spatially adaptive trained classifier using shared prior achieved statistically superior diagnostic performance compared to respective individual models, which further highlights the cross-disorder framework's efficacy on modeling limited-size datasets across disease domains.

0.37

Acoustic Biomarkers for Alzheimer's Disease Detection from Spontaneous Speech

eess.AS cs.LGcs.SD ·2026-09-30 ·Anh L Tran, Arjee Javellana Restar, Bereket Kindo
similarity 0.64
Abstract

Alzheimer's disease (AD) remains a major public health challenge, and early identification is crucial for timely intervention and care planning. Recent work has shown that speech-based digital biomarkers can capture subtle changes in vocal production, prosody, and timing that often precede or accompany cognitive decline. In this study, we investigate whether acoustic features extracted from spontaneous speech can reliably distinguish individuals with AD from healthy controls. Using a structured speech dataset derived from the Cookie Theft picture-description task, we extract clinically informative low-level descriptors spanning prosodic, spectral, and temporal domains, and evaluate a range of machine learning classifiers. Our results indicate that acoustic biomarkers carry strong discriminative value, with the best-performing models achieving clinically meaningful separation between diagnostic groups. These findings support the use of non-invasive, low-cost audio-based screening tools and motivate further work on multimodal and longitudinal assessment frameworks for dementia risk detection.

0.29

A Generalizable Feature Extractor for Alzheimer's-Related Brain MRI Tasks

cs.CV q-bio.QM ·2026-09-04 ·Reza Rajabli, D. Louis Collins
similarity 0.63
Abstract · 26 pages (excluding the references section), 7 figures (excluding sub-figures)

When there is not enough labeled data to properly train deep learning models, transfer learning can help. We still do not fully understand how effective it is in neuroimaging, especially for Alzheimer's disease research. It is also not clear if these transferred models can work on new datasets without being retrained for each specific task. We evaluate whether a compact, supervised pretrained model can serve as a reusable foundation model for downstream neuroimaging tasks. We freeze the 7.18 million weights of a 3D CNN previously trained for brain-age prediction, and adapt it to each task using Low-Rank Adaptation (LoRA), requiring only ~1% additional trainable parameters. We evaluate generalizability in six experiments. Adapting the model to classify cognitively normal versus Dementia on ADNI gave an AUC of 0.964 on held-out folds (Experiment #1). Applying that adapted model unchanged to OASIS-3, with no retraining, gave an AUC of 0.871 (Experiment #2). Reusing its output logit together with age and a cognitive score distinguished stable from progressing MCI with an AUC of 0.828 (Experiment #3). Adapting the same backbone to predict amyloid positivity from structural MRI gave an AUC of 0.804 (Experiment #4). Finally, the same approach estimated ICV-normalized hippocampal and white matter hypointensity volumes directly from the T1w image, with R^2 of 0.80 and 0.91 respectively, tasks normally addressed with much larger U-Net networks (Experiments #5 and #6). A compact model supervised on brain age can therefore serve as a reusable backbone, adapting to each task with ~1% additional parameters and transferring to an unseen cohort without any training. Our findings suggest that a carefully trained brain age model can serve as an effective foundation model for Alzheimer's related tasks, even under strict data constraints.

0.18

Leveraging a Foundation Model for the EEG-Based Diagnosis of Alzheimer's Disease

cs.LG q-bio.NC ·2026-08-27 ·Maggie Lin, Chung-Lin Hou, Tzyy-Ping Jung
published similarity 0.63
Abstract · 7 pages, 9 figures, 1 table. Accepted and presented at the 48th Annual International Conference of the IEEE Engineering in Medicine and Biol…

Biological heterogeneity in Alzheimer's Disease (AD) poses a critical diagnostic challenge, particularly for traditional linear methods that fail to capture non-linear neural dynamics. To address this, we propose a diagnostic framework utilizing the Large Brain Model (LaBraM), pretrained on over 2,500 hours of EEG data. By integrating these high-dimensional latent embeddings with a non-linear Random Forest classifier, our approach effectively isolates robust disease markers. Under a rigorous subject-independent 5-fold cross-validation protocol, the method achieves an ROC-AUC of 89.36% +/- 3.49%, PR AUC of 81.45% +/- 4.43%, and Balanced Accuracy of 82.44% +/- 4.34% in distinguishing dementia patients from healthy controls. Notably, this performance uses only 8-second EEG segments, surpassing traditional spectral baselines, including band-power and parameterized oscillatory features (FOOOF). Post-hoc occlusion analysis confirms the model captures clinically validated biomarkers, specifically occipital-frontal Alpha and Theta rhythm degradation. Additional neurophysiological alignment analysis demonstrated that higher LaBraM-predicted dementia probability significantly correlated with worse cognitive performance, greater clinical severity, increased theta and alpha relative power, and higher aperiodic exponent. These findings demonstrate that deep latent representations extract clinically relevant signatures from noisy signals, enabling precise, rapid, and data-efficient diagnosis.

0.30

Decoupling Parcellation from Classification: Systematic Benchmark of Fast Brain Segmentation Methods for Alzheimer's Disease Detection

eess.IV cs.AIcs.CV ·2026-08-17 ·Jiadao Zou, Hongyu Guo, Wei Xi
benchmark similarity 0.63
Abstract

Brain parcellation and classification are typically evaluated in isolation, yet downstream AD detection performance depends on their interaction. We decouple these components and systematically benchmark fast deep learning parcellation methods (SynthSeg+, OpenMAP-T1) against the FreeSurfer (FS-HV) clinical baseline through down- stream AD classification on OASIS-1. Our factorial design evaluates three parcellation methods, two volumetry strategies (hard vs. soft), and four classifier paradigms (clinical thresholds, supervised feedforward networks, ensemble methods, and foundation models with zero/few-shot prompting), with all results quantified using BCa Bootstrap 95% confidence intervals.

0.33